The Colombian Peritoneal Surface Malignancy Group was established as a collaborative academic initiative bringing together surgical teams and institutional programs dedicated to the study and treatment of peritoneal neoplasms. These groups have focused on the development and implementation of advanced therapeutic strategies, including cytoreductive surgery (CRS) and intraperitoneal chemotherapy, applied in carefully selected patients within a multidisciplinary framework.
The evolution of this field in Colombia has been progressive and sustained. Since 2007, with the leadership of the Fundación Santa Fe de Bogotá, a pathway of clinical and academic excellence has been established, achieving international recognition. In 2012, the National Cancer Institute further strengthened this effort by consolidating its institutional program, followed by the expansion of additional specialized groups across the country, including Clínica Colombia, Hospital Infantil Universitario de San José 2014, and centers in Medellín, Cali, and Bogotá, such as CTIC and Hospital San Ignacio.
A shared hallmark among these programs has been specialized training, adherence to international standards, and strong multidisciplinary collaboration, positioning Colombia as an emerging leader in the management of peritoneal surface malignancies in Latin America.